Page 37 - Vitamin D and Cancer

24 H.S. Cross

114. Newmark HL, Lipkin M (1992) Calcium, vitamin D, and colon cancer. Cancer Res 52
(7 Suppl):2067s–2070s
115. Newmark HL, Yang K, Lipkin M et al (2001) A Western-style diet induces benign and
malignant neoplasms in the colon of normal C57Bl/6 mice. Carcinogenesis
22(11):1871–1875
116. Cross HS, Lipkin M, Kallay E (2006) Nutrients regulate the colonic vitamin D system in
mice: relevance for human colon malignancy. J Nutr 136(3):561–564
117. Beer TM (2005) ASCENT: the androgen-independent prostate cancer study of calcitriol
enhancing taxotere. BJU Int 96(4):508–513
118. Hershberger PA, McGuire TF, Yu WD et al (2002) Cisplatin potentiates 1, 25-dihydroxyvi-
tamin D3-induced apoptosis in association with increased mitogen-activated protein kinase
kinase kinase 1 (MEKK-1) expression. Mol Cancer Ther 1(10):821–829
119. Trump DL, Hershberger PA, Bernardi RJ et al (2004) Anti-tumor activity of calcitriol:
pre-clinical and clinical studies. J Steroid Biochem Mol Biol 89–90(1–5):519–526
120. Trump DL, Muindi J, Fakih M, Yu WD, Johnson CS (2006) Vitamin D compounds: clinical
development as cancer therapy and prevention agents. Anticancer Res 26(4A):2551–2556
121. Tan J, Dwivedi PP, Anderson P et al (2007) Antineoplastic agents target the 25-hydroxyvi-
tamin D3 24-hydroxylase messenger RNA for degradation: implications in anticancer
activity. Mol Cancer Ther 6(12 Pt 1):3131–3138
122. Dwivedi PP, Hii CS, Ferrante A et al (2002) Role of MAP kinases in the 1,25-dihydroxyvi-
tamin D3-induced transactivation of the rat cytochrome P450C24 (CYP24) promoter.
Specific functions for ERK1/ERK2 and ERK5. J Biol Chem 277(33):29643–29653
123. Tang D, Wu D, Hirao A et al (2002) ERK activation mediates cell cycle arrest and apoptosis
after DNA damage independently of p53. J Biol Chem 277(15):12710–12717
124. Ting HJ, Hsu J, Bao BY, Lee YF (2007) Docetaxel-induced growth inhibition and apoptosis
in androgen independent prostate cancer cells are enhanced by 1alpha, 25-dihydroxyvitamin
D3. Cancer Lett 247(1):122–129
125. Belochitski O, Ariad S, Shany S, Fridman V, Gavrilov V (2007) Efficient dual treatment
of the hormone-refractory prostate cancer cell line DU145 with cetuximab and 1,
25- dihydroxyvitamin D3. In Vivo 21(2):371–376
126. Lechner D, Manhardt T, Bajna E, Posner GH, Cross HS (2007) A 24-phenylsulfone analog
of vitamin D inhibits 1alpha, 25-dihydroxyvitamin D(3) degradation in vitamin D
metabolism-competent cells. J Pharmacol Exp Ther 320(3):1119–1126
127. Nittke T, Kallay E, Manhardt T, Cross HS (2009) Parallel elevation of colonic 1,25-
dihydroxyvitamin D3 levels and apoptosis in female mice on a calcium-deficient diet.
Anticancer Res 29:3727–32
128. Horvath HC, Khabir Z, Nittke T, Gruber S, Speer G, Manhardt T, Bonner E, Kallay E (2010)
CYP24A1 splice variants-implications for the antitumorigenic actions of 1,25-(OH)2D3 in
colorectal cancer. J Steroid Biochem Mol Biol 121:76–9
129. Nittke T, Selig S, Kallay E, Cross HS (2008) Nutritional calcium modulates colonic expres-
sion of vitamin D receptor and pregnane X receptor target genes. Mol Nutr Food Res
52:S45–51